ctrl K

Watchlist Price Alert

Rapport Therapeutics Inc.... (RAPP)

NASDAQ: RAPP · Real-Time Price · USD

10.03

-0.79 (-7.30%)

At close: May 27, 2025, 2:54 PM

Rapport Therapeutics Common Stock Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Revenue	n/a	n/a	n/a
Cost of Revenue	n/a	112K	15K
Gross Profit	n/a	-112K	-15K
Operating Income	-83.06M	-36.18M	-10.37M
Interest Income	12.14M	2.53M	n/a
Pretax Income	-78.31M	-34.78M	-10.65M
Net Income	-78.31M	-34.79M	-10.65M
Selling & General & Admin	22.12M	8.07M	1.24M
Research & Development	60.94M	28M	9.12M
Other Expenses	n/a	n/a	n/a
Operating Expenses	83.06M	36.07M	10.35M
Interest Expense	n/a	n/a	285K
Selling & Marketing Expenses	n/a	-112K	n/a
Cost & Expenses	n/a	36.18M	10.37M
Income Tax Expense	n/a	10K	n/a
Shares Outstanding (Basic)	207.38M	180.79M	201.17M
Shares Outstanding (Diluted)	207.38M	180.79M	201.17M
EPS (Basic)	-0.38	-0.19	-0.05
EPS (Diluted)	-0.38	-0.19	-0.05
EBITDA	-77.47M	-34.66M	-10.35M
EBIT	-78.31M	-34.78M	-10.37M
Depreciation & Amortization	839K	112K	15K